SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laserscope (NASDAQ LSCP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Caroline who wrote ()11/9/1998 1:10:00 PM
From: Dick Martin  Read Replies (1) of 314
 
Laserscope Sells Hospital Equipment Business to Heraeus Medical Inc.;
Divestiture Returns Laserscope to Pure Laser Company

This seems to be good news from:
nt.excite.com
-- Dick Martin

SAN JOSE, Calif. (BW HealthWire) - Laserscope
(NASDAQ:LSCP) announced today that it has sold its
hospital equipment business unit to Heraeus Medical Inc., a
newly established division of Heraeus Holding, GmbH.

Laserscope acquired the hospital equipment business, later renamed Ascent Medical
Systems(TM)(AMS), as part of its acquisition in 1996 of Heraeus Surgical Inc. from Heraeus
MED GmbH, a subsidiary of Heraeus Holding.

"The sale of AMS is the planned outcome of the corporate restructuring goals announced in July
when we established AMS as a stand-alone business unit," said Robert V. McCormick, Laserscope
president and CEO. "The divestiture of AMS returns Laserscope to a pure laser company. It allows
management to concentrate its full attention on Laserscope's core business of leading-edge laser
systems and energy delivery devices for the office, outpatient center and hospital markets.

"Strategically, AMS did not fit with Laserscope's long-term plans," said McCormick. "We believe
the divestiture now will allow us to focus our energies on Laserscope's principal businesses and
future opportunities."

Laserscope will receive approximately $1 million in cash, subject to the release of $200,000 from
a related escrow account, and a settlement of $1.5 million in associated liabilities. Laserscope also
said it expects to take a non-operating charge in the range of up to $1,000,000 in the current
quarter directly related to the divestiture.

Laserscope designs, manufactures, sells and services on a worldwide basis an advanced line of
medical laser systems and related energy delivery devices. The Company is a pioneer in the
development and commercialization of lasers and advanced fiberoptic devices for a wide variety of
applications, including photodynamic therapy to treat cancer and other diseases. More information
on Laserscope and its products can be found on the Company's Web site at www.laserscope.com or
www.photodynamictherapy.com.
>>>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext